|
[1]
|
Hann, H.W., Stahlhut, M.W. and Menduke, H. (1991) Iron en- hances tumor growth. Observation on spontaneous mammary tumors in mice. Cancer, 68, 2407-2410.
|
|
[2]
|
Hann, H.W., Stahlhut, M.W. and Blumberg, B.S. (1988) Iron nutrition and tumor growth: Decreased tumor growth in iron- deficient mice. Cancer Research, 48, 4168-4170.
|
|
[3]
|
Drakesmith, H. and Prentice, A. (2008) Viral infection and iron metabolism. Nature Reviews Microbiology, 6, 541-552.
|
|
[4]
|
Stevens, R.G., Jones, D.Y., Micozzi, M.S., et al. (1988) Body iron stores and the risk of cancer. New England Journal of Med- icine, 319, 1047-1052.
|
|
[5]
|
Huang, X. (2003) Iron overload and its association with cancer risk in humans: Evidence for iron as a carcinogenic metal. Mu- tation Research, 533, 153-171.
|
|
[6]
|
Richardson, D.R., Kalinowski, D.S., Lau S., et al. (2009) Cancer cell iron metabolism and the development of potent iron chela- tors as anti-tumour agents. Biochimica et Biophysica Acta, 1790, 702-717.
|
|
[7]
|
Huang, X., Dai, J., Fournier, J., et al. (2002) Ferrous ion autoxi- dation and its chelation in iron-loaded human liver HepG2 cells. Free Radical Biology & Medicine, 32, 84-92.
|
|
[8]
|
Palmer, H.J. and Paulson, K.E. (1997) Reactive oxygen species and antioxidants in signal transduction and gene expression. Nu- trition Reviews, 55, 353-361.
|
|
[9]
|
Siegel, E.M., Patel, N., Lu, B., et al. (2012) Circulating bio- markers of iron storage and clearance of incident human papil- lomavirus infection. Cancer Epidemiology, Biomarkers & Pre- vention, 21, 859-865.
|
|
[10]
|
顾庆, 杨朝晖, 薛金玲等 (2007) 晚期宫颈癌患者在动脉介入化疗前后血清铁含量变化的探讨. 河北医学, 13, 383-385.
|
|
[11]
|
吴国芳, 李青旺, 李健等 (2009) 人乳铁蛋白对宫颈癌Hela细胞凋亡的影响. 黑龙江畜牧兽医(科技版), 11, 70.
|
|
[12]
|
Radha, K.S., Sugiki, M., Yoshida, E., et al. (2005) Iron-mediated stability of PAI-1 mRNA in adenocarcinoma cells-involvement of a mRNA-binding nuclear protein. Thrombosis Research, 116, 255-263.
|
|
[13]
|
Drakesmith, H. and Prentice, A. (2008) Viral infection and iron metabolism. Nature Reviews Microbiology, 6, 541-555.
|
|
[14]
|
Eaton, J.W. and Qian, M. (2002) Molecular bases of cellular iron toxicity. Free Radical Biology & Medicine, 32, 833-840.
|
|
[15]
|
吴训贤 (1992) 铁摄入过量对健康影响. 国外医学医学地理分册, 13, 100.
|
|
[16]
|
Weinberg, E.D. (1983) Iron in neoplastic disease. Nutrition Can- cer, 4, 223-233.
|
|
[17]
|
Potischman, N. and Brinton, L.A. (1996) Nutrition and cervical neoplasia. Cancer Causes Control, 7, 113-126.
|
|
[18]
|
Pham, C.G., Bubici, C., Zazzeroni, F., Papa, S., Jones, J., Alva- rez, K., et al. (2004) Ferritin heavy chain upregulation by NF- kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell, 119, 529-542.
|
|
[19]
|
Poljak-Blazi, M., Jaganjac, M., Sabol, I., et al. (2011) Effect of ferric ions on reactive oxygen species formation, cervical cancer cell lines growth and E6/E7 oncogene expression. Toxicology in Vitro, 25, 160-166.
|
|
[20]
|
Simonart, T., Boelaert, J.R., Mosselmans, R., et al. (2002) Anti- proliferative and apoptotic effects of iron chelators on human- cervical carcinoma cells. Gynecologic Oncology, 85, 95-102.
|
|
[21]
|
Simonart, T., Boelaert, J.R., Andrei, G., et al. (2003) Iron with- drawal strategies fail to prevent the growth of SiHa-induced tu- mors in mice. Gynecologic Oncology, 90, 91-95.
|
|
[22]
|
Takahiro, Y., Shuji, T., Isao, S., et al. (2011) Deferoxamine for advanced hepatocellular carcinoma. New England Journal of Medicine, 365, 576-578.
|